000 | 01821 a2200565 4500 | ||
---|---|---|---|
005 | 20250515022551.0 | ||
264 | 0 | _c20060818 | |
008 | 200608s 0 0 eng d | ||
022 | _a1684-1182 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCheng, Yu-Ren | |
245 | 0 | 0 |
_aRisk factors for candidemia-related mortality at a medical center in central Taiwan. _h[electronic resource] |
260 |
_bJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi _cApr 2006 |
||
300 |
_a155-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAPACHE |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aCandida _xclassification |
650 | 0 | 4 |
_aCandidiasis _xdrug therapy |
650 | 0 | 4 | _aCatheterization, Central Venous |
650 | 0 | 4 |
_aCommunity-Acquired Infections _xdrug therapy |
650 | 0 | 4 |
_aCross Infection _xdrug therapy |
650 | 0 | 4 | _aDiabetes Complications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluconazole _xpharmacology |
650 | 0 | 4 |
_aFungemia _xdrug therapy |
650 | 0 | 4 | _aHospitals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aShock |
650 | 0 | 4 | _aStatistics as Topic |
650 | 0 | 4 | _aTaiwan |
700 | 1 | _aLin, Li-Chen | |
700 | 1 | _aYoung, Tzuu-Guang | |
700 | 1 | _aLiu, Chun-Eng | |
700 | 1 | _aChen, Chang-Hua | |
700 | 1 | _aTsay, Ren-Wen | |
773 | 0 |
_tJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi _gvol. 39 _gno. 2 _gp. 155-61 |
|
999 |
_c16209665 _d16209665 |